CVS Health (CVS) said Monday it has appointed four board members following "productive discussions" with Glenview Capital Management.
The company said it added Leslie Norwalk, Larry Robbins, Guy Sansone and Doug Shulman to the board, bringing its total members to 16.
Norwalk is a strategic counsel to various health care companies; Robbins is the founder and chief executive of Glenview Capital Management; Sansone is the chairman and CEO of H2 Health, and Shulman is the chairman of OneMain Holdings.
In connection with the appointments, the company said it has entered into a confidentiality agreement with Glenview, wherein the latter agreed to customary confidentiality, standstill and other provisions.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。